Africa Pharmaceutical Market Anticipated to Grow at a CAGR of 20.4% during 2016-2024

New York, USA, 2018-Dec-07 — /EPR Network/ —  According to Goldstein Research, Africa Pharmaceutical Market is expected to reach USD 160.7 billion by 2024, growing at a CAGR of 20.4% over the forecast period 2016-2024. major driving factor for Africa pharmaceutical market is the expansion of healthcare capacity which according to the World Bank Africa acquired 70,000 new hospital beds, 16,000 doctors, and 60,000 nurses, adding up to a total of 1,050,000 beds, 498,370 doctors, and 1,250,000 nurses between 2005 and 2012. Further, based on geography, Africa pharmaceutical market is impacted by the factors such as healthcare challenges in Ghana, Senegal, Tanzania, Kenya, Benin and Malawi among others in Africa, which thus hold the opportunities in future. South Africa has the largest market in pharmaceuticals among other African countries. Also, the health care system in Uganda is in a mess due to lack of government incentives while Zambia is the ideal country when it comes to how a democracy should work.

Browse Full Report:

Market Segmentation

On the basis of our in-depth analysis, Africa Pharmaceutical Market can be segmented as follows:

By Type

  • Active Pharmaceutical Ingredients (APIs)
  • Branded
  • Generics
  • Contract Research and Manufacturing Services
  • Formulations (CRAMS)
  • Chronic
  • Cardiovascular
  • Anti-Diabetes
  • Gastro Intestinal
  • Neurological
  • Acute
  • Anti-infectives
  • Respiratory
  • Pain
  • Gynecology
  • Biosimilars

By Geography

  • Nigeria Pharmaceutical Market Analysis, 2016-2024
  • Egypt Pharmaceutical Market Analysis, 2016-2024
  • South Africa Pharmaceutical Market Analysis, 2016-2024
  • Algeria Pharmaceutical Market Analysis, 2016-2024
  • Morocco Pharmaceutical Market Analysis, 2016-2024
  • Ethiopia Pharmaceutical Market Analysis, 2016-2024
  • Kenya Pharmaceutical Market Analysis, 2016-2024
  • Rest of the Africa Pharmaceutical Market Analysis, 2016-2024

 Download Exclusive Sample Report:

“Africa Pharmaceutical Market Outlook 2024” contains a detailed overview of the Africa pharmaceutical market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by type and geography.

The Africa Pharmaceutical Market Report highlights the competitive outlook of major Africa players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of pharmaceutical market report will help the clients to assess their business strategies as per the competitive environment in the market space.

Major players of the Africa pharmaceutical market discussed in the report are: Sun Pharma, Cipla, Candila. Glenmark, Glaxo SmithKline, Abbott Africa, Biocon, Jubilant life, Sanofi Africa, Elys, Pfizer, Cosmos, Bayer, Emzor, Fidson, Dawa, Regal, Lab and Allied, Roche, AstraZeneca, Merck, etc.

Further, Africa Pharmaceutical Market Report encompasses the major trends & growth opportunities, market dynamics, and other growth factors. The Pharmaceutical Market outlook also comprises of key challenges for the market players, risk analysis, SWOT Analysis, USP Analysis, BPS analysis, and Market Attractiveness. The report also includes the expert analysis which provides a complete overview of the market post analysis of the economic, political, environmental & social factors of each region and country.

Advancement in mentioned below industries are driving the Africa Pharmaceutical Market

Nigeria Pharmaceutical Market

According to Goldstein Research, regional government initiatives to curb the import and distribution of counterfeit medicines and significant investment by the government to develop a matured business environment are the major factors for the growth of Nigeria pharmaceutical Market in the country.

India Pharmaceutical Market

According to Goldstein Research, India is the supplier of approximately 20% of generic medicines across the globe, in terms of volume which makes it the largest provider of generic medicines globally and the volumes are projected to expand in coming years. Huge expenditures by the Indian government to modernize the healthcare infrastructure and market players significant investment over R&D activities is also driving the growth of the India Pharmaceutical Market

Singapore Pharmaceuticals Market

Singapore Pharmaceuticals Market is expected togrow at a CAGR of 6.40%. The adaptation of modern technologies and developmental activities for cost effective medical services is driving the growth of pharmaceutical industry and providing attractive opportunities to foreign investors as well as to local startups.It is expected by 2024, Singapore medical device market may reach over USD 530 million.


Matched content

Editor’s pick

Express Press Release Distribution